Lincolnshire-based Nexus Pharmaceuticals Inc. said it has received U.S. Food and Drug Administration approval of the drug Emerphed administered using various sizes of its single-dose, pre-filled syringes.
Related posts
-
‘We’re all in this together’: Hawthorn Woods looks for long-term water option
Hawthorn Woods working toward economically and logistically viable long-term water solutions -
Man faces sentencing for 2021 Round Lake bank robbery
The Lake County Attorney's Office said Francisco Martinez, 32, entered a First Midwest Bank branch in... -
Man charged with stealing from store, again, a few hours after release from jail
A man has been charged with stealing from the Oak Brook Macy’s store a few hours...